跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2611.05106 · v1

Label-Preserving Fourier Domain Adaptation with Generative-AI and Real Style Donors for 3D Mitral Valve Segmentation

首次提交 2026-11-04 00:01
版本更新 2026-11-04 00:01
雷达观测 2026-11-04 23:39
arXiv ↗PDF ↗

摘要

Accurate segmentation of the mitral valve from three-dimensional transesophageal echocardiography (3D TEE) is severely restricted by the scarcity of publicly available expert- annotated volumetric datasets. To address this critical limitation, we investigated Fourier Domain Adaptation (FDA), utilizing general-purpose generative-AI images (from platforms like Chat- GPT, Google Gemini, and Microsoft MAI) as annotation-free style donors for 3D mitral valve segmentation. We employed a DeepMitral residual U-Net model on the public MVSeg2023 dataset, comparing six conditions over three runs: real-only training, traditional augmentation, FDA with each generative source, and a non-AI FDA control using real-image style donors, plus an optimization-matched real-only control and a \b{eta} sensitivity analysis. Case-level paired testing showed that FDA with these generative sources led to significant reductions in boundary- and surface-related errors across all three donor conditions relative to the primary real-only baseline. However, the impact on the core segmentation metric, Generalized Dice Score (GDS), proved generator-dependent. ChatGPT-FDA showed a significant GDS advantage over the optimization-matched control but not over the primary baseline, and Gemini-FDA showed no significant GDS difference. Notably, only MAI-FDA provided a statistically robust and significant increase in GDS compared to the primary baseline. The \b{eta} sensitivity was not robust across training runs. These findings confirm that FDA remains an important augmentation mechanism. While generative-AI images offer a practical means of acquiring style diversity without new annotations, the non-AI control performed comparably to ChatGPT-FDA, so we do not conclude that this approach is superior to training with real-image donors.

作者备注:7 pages, 1 figure, 3 tables, submitted to IEEE for possible publication

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

目前只观测到一个版本,无法比较变化。之后收录新版本时,会在这里对照标题、作者、分类和摘要。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v1 · 2026-11-04 00:01 · 最新观测版本

Label-Preserving Fourier Domain Adaptation with Generative-AI and Real Style Donors for 3D Mitral Valve Segmentation

Accurate segmentation of the mitral valve from three-dimensional transesophageal echocardiography (3D TEE) is severely restricted by the scarcity of publicly available expert- annotated volumetric datasets. To address this critical limitation, we investigated Fourier Domain Adaptation (FDA), utilizing general-purpose generative-AI images (from platforms like Chat- GPT, Google Gemini, and Microsoft MAI) as annotation-free style donors for 3D mitral valve segmentation. We employed a DeepMitral residual U-Net model on the public MVSeg2023 dataset, comparing six conditions over three runs: real-only training, traditional augmentation, FDA with each generative source, and a non-AI FDA control using real-image style donors, plus an optimization-matched real-only control and a \b{eta} sensitivity analysis. Case-level paired testing showed that FDA with these generative sources led to significant reductions in boundary- and surface-related errors across all three donor conditions relative to the primary real-only baseline. However, the impact on the core segmentation metric, Generalized Dice Score (GDS), proved generator-dependent. ChatGPT-FDA showed a significant GDS advantage over the optimization-matched control but not over the primary baseline, and Gemini-FDA showed no significant GDS difference. Notably, only MAI-FDA provided a statistically robust and significant increase in GDS compared to the primary baseline. The \b{eta} sensitivity was not robust across training runs. These findings confirm that FDA remains an important augmentation mechanism. While generative-AI images offer a practical means of acquiring style diversity without new annotations, the non-AI control performed comparably to ChatGPT-FDA, so we do not conclude that this approach is superior to training with real-image donors.

查看此版本解读 →查看此版本原文 ↗